[Laboratory and clinical investigation on amikacin (BB-K8) in complicated infections of the urological field (author's transl)].
D000328:Adult; D000368:Aged; D000613:Aminobutyrates / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use / Q000652:urine; D003556:Cystitis / Q000188:drug therapy; D005260:Female; D006801:Humans; D007612:Kanamycin / Q000009:adverse effects / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use* / Q000652:urine; D007709:Klebsiella / Q000187:drug effects; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D011472:Prostatitis / Q000188:drug therapy; D011511:Proteus / Q000187:drug effects; D011549:Pseudomonas / Q000187:drug effects; D011704:Pyelonephritis / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects; D013291:Streptococcus / Q000187:drug effects; D014570:Urologic Diseases / Q000188:drug therapy*
D000613:Aminobutyrates; D007612:Kanamycin